Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Omega Advisors U.S. Capital Appreciation Fund Announces Amendment to Normal Course Issuer Bid


Print article Print article
© Marketwire 2012
2012-11-09 16:50:12 -

TORONTO, ONTARIO -- (Marketwire) -- 11/09/12 -- Omega Advisors U.S. Capital Appreciation Fund (TSX:OUS.UN) (the "Fund"), today announced an amendment to the normal course issuer bid (the "Bid") for its class A units ("Units").



As at November 8, 2012, the Fund has 3,835,051 Units issued and outstanding. Under the amendment to the Bid, the Fund may purchase up to 330,875 Units in aggregate from the period beginning on September 4, 2012 and ending on September 3, 2013 representing 10% of the Fund's public float of 3,308,751, and may not, in any 30 day period, purchase more than 76,701 Units representing 2% of the Units issued and outstanding. All Units purchased pursuant to the Bid will be cancelled. Unit purchases will be made only through facilities of the TSX and will be in accordance with the TSX's rules and policies.


The Bid commenced on September 4, 2012 and will terminate on the earlier of the date on which the Fund completes its purchases pursuant to the Bid or September 3, 2013. Under the Bid, the Fund has purchased a total of 46,200 Units at an average price of $9.69.


SOURCE: Omega Advisors U.S. Capital Appreciation Fund


For further information: please contact your financial advisor, call Artemis Investment Management's investor relations line at (647) 477-4886 or visit our website at www.artemisfunds.ca.



Contacts:

Artemis Investment Management

Investor relations

(647) 477-4886

www.artemisfunds.ca



Press Information:




Contact Person:


Disclaimer: (c) 2013 Market Wire. All of the press releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Market Wire's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser